The Outcomes of Hypertransfusion in Major ABO Incompatible Allogeneic Stem Cell Transplantation

Major ABO incompatibility may be potentially associated with immediate or delayed hemolysis and delayed onset of erythropoiesis in patients receiving allogeneic hematopoietic stem cell transplantation (HSCT). To determine if hemolysis can be prevented by the inhibition of graft erythropoiesis, we pe...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Se Hoon, Lee, Mark Hong, Lee, Se Hoon, Lee, Kyung-Eun, Park, Jinny, Park, Joon Oh, Kim, Kihyun, Kim, Won Seog, Jung, Chul Won, Im, Young-Hyuk, Kang, Won Ki, Park, Keunchil, Kim, Seon Woo, Lee, Kyoo Hyung, Lee, Je Hwan
Formato: Texto
Lenguaje:English
Publicado: The Korean Academy of Medical Sciences 2004
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2822268/
https://www.ncbi.nlm.nih.gov/pubmed/14966346
http://dx.doi.org/10.3346/jkms.2004.19.1.79

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2822268/
https://www.ncbi.nlm.nih.gov/pubmed/14966346
http://dx.doi.org/10.3346/jkms.2004.19.1.79

Ejemplares similares